Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Sator-Katzenschlager, S; Fiala, K; Kress, HG; Kofler, A; Neuhold, J; Kloimstein, H; Ilias, W; Mozes-Balla, EM; Pinter, M; Loining, N; Fuchs, W; Heinze, G; Likar, R.
Subcutaneous target stimulation (STS) in chronic noncancer pain: a nationwide retrospective study.
Pain Pract. 2010; 10(4): 279-86.
Doi: 10.1111/j.1533-2500.2009.00351.x
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Likar Rudolf
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Stimulation of primary afferent neurons offers a new approach for the control of localized chronic pain. We describe the results with a new neurostimulation technique, subcutaneous target stimulation (STS), for the treatment of chronic focal noncancer pain. STS applies permanent electrical stimulation directly at the painful area via a percutaneous-placed subcutaneous lead. We reported the clinical outcomes of 111 patients with focal chronic, noncancer pain treated with STS in this first nationwide, multicenter retrospective analysis. The indications for STS were low back pain (n = 29) and failed back surgery syndrome (back pain with leg pain) (n = 37), cervical neck pain (n = 15), and postherpetic neuralgia (n = 12). Pain intensity was measured on a numerical rating scale (NRS) before and after implantation. Data on analgesic medication, stimulation systems, position, and type of leads and complications were obtained from the patients' records. After implantation, the mean pain intensity improved by more than 50% (mean NRS reduction from 8.2 to 4.0) in the entire patient group (P = 0.0009). This was accompanied by a sustained reduction in demand for analgesics. In all the patients, the STS leads were positioned directly at the site of maximum pain. Lead dislocation occurred in 14 patients (13%), infections in 7 (6%), and in 6 cases (5%), lead fractures were observed. The retrospective data analysis revealed that STS effectively provided pain relief in patients suffering from refractory focal chronic noncancer pain and that STS is an alternative treatment option. Prospective controlled studies are required to confirm these retrospective findings. This article presents a new minimally invasive technique for therapy-resistant focal pain.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult - administration & dosage
- Aged - administration & dosage
- Aged, 80 and over - administration & dosage
- Analgesics - therapeutic use
- Austria - administration & dosage
- Biophysics - administration & dosage
- Chronic Disease - administration & dosage
- Electric Stimulation Therapy - methods
- Electrodes, Implanted - administration & dosage
- Female - administration & dosage
- Humans - administration & dosage
- Male - administration & dosage
- Middle Aged - administration & dosage
- Pain - classification, drug therapy
- Pain Management - administration & dosage
- Pain Measurement - methods
- Retrospective Studies - administration & dosage
- Skin - innervation
- Treatment Outcome - administration & dosage
- Find related publications in this database (Keywords)
- chronic focal pain
- neuropathic pain
- neuromodulation
- subcutaneous target stimulation